Cargando…

Extracorporeal Membrane Oxygenation Complications in Heparin- and Bivalirudin-Treated Patients

OBJECTIVES: Extracorporeal membrane oxygenation is a potentially life-saving intervention in refractory cardiopulmonary failure, but it requires anticoagulation to prevent circuit thromboses, which exposes the patient to hemorrhagic complications. Heparin has traditionally been the anticoagulant of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giuliano, Katherine, Bigelow, Benjamin F., Etchill, Eric W., Velez, Ana K., Ong, Chin Siang, Choi, Chun W., Bush, Errol, Cho, Sung-Min, Whitman, Glenn J. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280085/ https://www.ncbi.nlm.nih.gov/pubmed/34278315 http://dx.doi.org/10.1097/CCE.0000000000000485

Ejemplares similares

Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation
por: Ranucci, Marco, et al.
Publicado: (2011)

Superiority of bivalirudin over heparin anticoagulation therapy for extracorporeal membrane oxygenation? Too early to draw conclusions
por: Gu, Jie, et al.
Publicado: (2023)

Heparin-based versus bivalirudin-based anticoagulation in pediatric extracorporeal membrane oxygenation: A systematic review
por: Valdes, Carlos A., et al.
Publicado: (2023)

The Efficacy and Safety of Bivalirudin Versus Heparin in the Anticoagulation Therapy of Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis
por: Ma, Min, et al.
Publicado: (2022)

Management of Bivalirudin Anticoagulation Therapy for Extracorporeal Membrane Oxygenation in Heparin-Induced Thrombocytopenia: A Case Report and a Systematic Review
por: Zhong, Han, et al.
Publicado: (2020)

Bivalirudin for Maintenance Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation for COVID-19
por: Seelhammer, Troy G., et al.
Publicado: (2021)

Neurological Complications in COVID-19 Patients With ECMO Support: A Systematic Review and Meta-Analysis
por: Kannapadi, Nivedha V., et al.
Publicado: (2022)

Bivalirudin for cardiopulmonary bypass in a patient with heparin allergy
por: Boysan, Emre, et al.
Publicado: (2023)

Bivalirudin versus heparin in primary PCI: clinical outcomes and cost analysis
por: Deharo, Pierre, et al.
Publicado: (2018)

Left heart decompression in patients supported with extracorporeal membrane oxygenation for cardiac disease
por: Ong, Chin Siang, et al.
Publicado: (2017)

Bivalirudin in Combination with Heparin to Control Mesenchymal Cell Procoagulant Activity
por: Stephenne, Xavier, et al.
Publicado: (2012)

Extracorporeal Membrane Oxygenation Retrieval in Coronavirus Disease 2019: A Case-Series of 19 Patients Supported at a High-Volume Extracorporeal Membrane Oxygenation Center
por: Riera, Jordi, et al.
Publicado: (2020)

Neurologic Injury in Patients With COVID-19 Who Receive VV-ECMO Therapy: A Cohort Study
por: Kannapadi, Nivedha V., et al.
Publicado: (2021)

Resting Energy Expenditure of Patients on Venovenous Extracorporeal Membrane Oxygenation for Adult Respiratory Distress Syndrome: A Pilot Study
por: Ong, Chin Siang, et al.
Publicado: (2022)

Distinct Effects of Unfractionated Heparin versus Bivalirudin on Circulating Angiogenic Peptides
por: Kapur, Navin K., et al.
Publicado: (2012)

EFFECT OF HEPARIN AND BIVALIRUDIN ON THE KINETICS OF CLOT FORMATION: VISCOELASTIC COAGULATION TESTING
por: Hasija, Suruchi, et al.
Publicado: (2017)

Periprocedural anticoagulation in transcatheter aortic valve replacement: Heparin vs bivalirudin
por: Minhas, Abdul Mannan Khan, et al.
Publicado: (2017)

Neuron-Specific Enolase Levels in Adults Under Venoarterial Extracorporeal Membrane Oxygenation
por: Reuter, Jean, et al.
Publicado: (2020)

Right Ventricular Dysfunction and Mortality After Cannulation for Venovenous Extracorporeal Membrane Oxygenation
por: Ortiz, Fernando, et al.
Publicado: (2020)

Early posthospitalization recovery after extracorporeal membrane oxygenation in survivors of COVID-19
por: Taylor, Lauren J., et al.
Publicado: (2022)

Bivalirudin or heparin: which anticoagulation strategy for critically ill cardiac surgery patients?
por: Pappalardo, F, et al.
Publicado: (2014)

Clinical efficacy of extracorporeal membrane oxygenation in cardiogenic shock patients: a multi-center study
por: Dai, Qing-Qing, et al.
Publicado: (2020)

Heparin-like effect in postcardiotomy extracorporeal membrane oxygenation patients
por: Ranucci, Marco, et al.
Publicado: (2014)

Extracorporeal Membrane Oxygenation Support for Failure to Wean From Cardiopulmonary Bypass After Pediatric Cardiac Surgery: Analysis of Extracorporeal Life Support Organization Registry Data
por: Sperotto, Francesca, et al.
Publicado: (2020)

Extracorporeal Membrane Oxygenation Support for Influenza A: Retrospective Review of the Extracorporeal Life Support Organization Registry Comparing H1N1 With Other Subtypes
por: O’Neil, Erika R., et al.
Publicado: (2021)

Outcomes of Patients Undergoing Interfacility Extracorporeal Membrane Oxygenation Transfer Based on Cannulation Location and Mode of Transport
por: Wothe, Jillian K., et al.
Publicado: (2022)

Bivalirudin Anticoagulation in Extracorporeal Membrane Oxygenation (ECMO) for Severe Coronaviral Disease (COVID-19) Related Acute Respiratory Distress Syndrome (ARDS)
por: Kumar, S., et al.
Publicado: (2022)

Bivalirudin Versus Heparin During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction
por: Patel, Hiten, et al.
Publicado: (2019)

The Implementation and Outcomes of a Nurse-Run Extracorporeal Membrane Oxygenation Program, a Retrospective Single-Center Study
por: Odish, Mazen, et al.
Publicado: (2021)

Assessing the SAfety and FEasibility of bedside portable low-field brain Magnetic Resonance Imaging in patients on ECMO (SAFE-MRI ECMO study): study protocol and first case series experience
por: Cho, Sung-Min, et al.
Publicado: (2022)

Heparin-Induced Thrombocytopenia in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation
por: Lüsebrink, Enzo, et al.
Publicado: (2023)

Plasma Transfusion and Procoagulant Product Administration in Extracorporeal Membrane Oxygenation: A Secondary Analysis of an International Observational Study on Current Practices
por: van Haeren, Maite M.T., et al.
Publicado: (2023)

Long-term outcomes of high-risk percutaneous coronary interventions under extracorporeal membrane oxygenation support: An observational study
por: Huang, Yi-Xiong, et al.
Publicado: (2022)

Outcomes of Extracorporeal Membrane Oxygenation in COVID-19–Induced Acute Respiratory Distress Syndrome: An Inverse Probability Weighted Analysis
por: Raasveld, Senta Jorinde, et al.
Publicado: (2022)

Outcomes of Patients Transported in the Prone Position to a Regional Extracorporeal Membrane Oxygenation Center: A Retrospective Cohort Study
por: Zhang, Timothy, et al.
Publicado: (2023)

The Emerging Role of Bivalirudin for Therapeutic Anticoagulation in Patients With Coronavirus Disease 2019 Requiring Extracorporeal Membrane Oxygenation Support: Is It Time to Change the Routine Practice?
por: Tahan, Mohamed R. El
Publicado: (2022)

Heparin Versus Bivalirudin in Acute Myocardial Infarction: Unfractionated Heparin Monotherapy Elevated to Primary Treatment in Contemporary Percutaneous Coronary Intervention
por: Centurión, Osmar Antonio
Publicado: (2016)

Treatment of Bronchopleural and Alveolopleural Fistulas in Acute Respiratory Distress Syndrome With Extracorporeal Membrane Oxygenation, a Case Series and Literature Review
por: Odish, Mazen F., et al.
Publicado: (2021)

Neurologic Complications of Extracorporeal Membrane Oxygenation
por: Nasr, Deena M, et al.
Publicado: (2015)

Contemporary analysis of charges and mortality in the use of extracorporeal membrane oxygenation: A cautionary tale
por: Hayanga, J.W. Awori, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lstuc9r2c6c3722bl1s6ao8pbt